Skip to main content

Table 1 Clinical features of NSCLC patients

From: Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma

Items

NSCLC patients (N = 381)

Age (years), mean±SD

61.0 ± 10.3

Gender (male/female), No.

286/95

History of smoke, No. (%)

208 (54.6)

History of drink, No. (%)

150 (39.4)

Common complications, No. (%)

 

 Hypertension

146 (38.3)

 Hyperlipidemia

120 (31.5)

 Diabetes

62 (16.3)

Differentiation, No. (%)

 

 Well

56 (14.7)

 Moderate

228 (59.8)

 Poor

97 (25.5)

Tumor size (cm), mean±SD

5.2 ± 2.1

LYN metastasis, No. (%)

134 (35.2)

TNM stage, No. (%)

 

 I

131 (34.4)

 II

107 (28.1)

 III

143 (37.5)

CEA (ng/mL), median (IQR)

6.6 (3.2–27.1)

  1. NSCLC non-small cell lung carcinoma; SD standard deviation; LYN lymph node; CEA carcinoembryonic antigen; IQR interquartile range